Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 04:12 pm
Share
Sunmax Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was TWD 196.128 million compared to TWD 155.074 million a year ago. Operating income was TWD 91.457 million compared to TWD 51.260 million a year ago. Net income was TWD 60.978 million compared to TWD 33.181 million a year ago. Basic earnings per share was TWD 1.12 compared to TWD 0.61 a year ago. For the half year, total revenue was TWD 367.018 million compared to TWD 250.571 million a year ago. Operating income was TWD 187.988 million compared to TWD 69.462 million a year ago. Net income was TWD 117.280 million compared to TWD 55.853 million a year ago. Basic earnings per share was TWD 2.15 compared to TWD 1.03 a year ago. Diluted earnings per share was TWD 2.15 compared to TWD 1.02 a year ago.
SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.